Appointment booking for Dr. Melissa Lindenau, MD is currently not available.Dr. Melissa Lindenau, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Melissa Lindenau, MD (she/her) is a Pediatrician in Oklahoma City, OK with over 17 years of experience. What is your opinion of Dr. Melissa Lindenau, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Melissa Lindenau, MD has received over $1,460 which includes payments from the following companies:
$307.33 from Shire North American Group Inc
$231.07 from Pfizer Inc.
$113.67 from AstraZeneca Pharmaceuticals LP
$105.95 from Neos Therapeutics, LP
$91.04 from Mylan Specialty L.P.
$77.27 from Rhodes Pharmaceuticals L.P.
$65.75 from sanofi-aventis U.S. LLC
$65.46 from Tris Pharma Inc
$63.41 from Sanofi Pasteur Inc.
$42.27 from Merck Sharp & Dohme Corporation
$37.40 from Novartis Pharmaceuticals Corporation
$35.98 from Kaleo, Inc.
$33.78 from Sobi, Inc
$32.90 from Arbor Pharmaceuticals, Inc.
$21.44 from Lupin Pharmaceuticals, Inc
$21.00 from MedImmune, LLC
$19.12 from Lupin Inc.
$19.07 from Ironshore Pharmaceuticals Inc.
$18.71 from GlaxoSmithKline, LLC.
$17.61 from Adlon Therapeutics L.P.
Payments received by Dr. Melissa Lindenau, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!